scispace - formally typeset
D

Diana Pignalosa

Researcher at GSI Helmholtz Centre for Heavy Ion Research

Publications -  14
Citations -  279

Diana Pignalosa is an academic researcher from GSI Helmholtz Centre for Heavy Ion Research. The author has contributed to research in topics: Embryonic stem cell & Embryoid body. The author has an hindex of 7, co-authored 14 publications receiving 240 citations. Previous affiliations of Diana Pignalosa include Darmstadt University of Applied Sciences.

Papers
More filters
Journal ArticleDOI

Effects of sparsely and densely ionizing radiation on plants

TL;DR: Main results from studies on the effect of ionizing radiations, including cosmic rays, on plants, focusing on genetic alterations, modifications of growth and reproduction and changes in biochemical pathways especially photosynthetic behaviour confirm what is known from animal studies: densely ionizing radiator are more efficient in inducing damages at several different levels, in comparison with sparsely ionizing radiation.
Journal ArticleDOI

Influence of Nuclear Geometry on the Formation of Genetic Rearrangements in Human Cells

TL;DR: The results demonstrate that the architecture of the cell nucleus determines the formation of chromosomal rearrangements, and it is shown that interphase chromosomes are divided into discrete domains, with limited overlapping and movement.
Journal ArticleDOI

Mouse embryonic stem cells that survive γ-rays exposure maintain pluripotent differentiation potential and genome stability.

TL;DR: Results indicate a commitment of mESCs to maintain pluripotency and genome stability and the chromosomal damage observed in the progeny of the survived cells after 5 Gy exposure is significantly higher than that observed in control samples, although it is mostly of the stable and transmissible type.
Journal ArticleDOI

Chromosome inversions in lymphocytes of prostate cancer patients treated with X-rays and carbon ions

TL;DR: The study suggests that the risks of normal tissue late effects and second malignancies in prostate cancer patients are comparable when heavy ions or IMRT radiotherapy are applied.